MPs Geir Pollestad and Kjersti Toppe propose measures to increase Norwegian production of medicines and medical equipment and strengthen emergency preparedness. The proposers argue that despite multiple Storting resolutions, the government has yet to conclude emergency supply agreements between Norwegian authorities and pharmaceutical manufacturers, and that national production capacity must become an operational part of medicine preparedness.
AI-generated summary · Model: Claude Haiku 4.5 · Generated: 14 May 2026
These are the proposals in the document, not decisions. See the votes for the outcome.
The Storting calls on the government to present new measures for increased Norwegian production of medicines and medical equipment, and to report back to the Storting as soon as possible.
The Storting calls on the government to promptly conclude emergency supply agreements with factories in Norway for the production of critical medicines and medical equipment, and to return to the Storting with necessary proposals.
The Storting calls on the government to ensure that the Norwegian Medicines Agency receives a clearer mandate and necessary tools to conclude and manage emergency supply agreements for the production of medicines and medical equipment.
The Storting calls on the government to explore the possibilities for Nordic joint procurement arrangements for emergency stockpiles of medicines and medical equipment.
The Storting calls on the government to extend stockpiling requirements for medicines to also include active pharmaceutical ingredients relevant to emergency supply agreements with Norwegian producers.
The Storting calls on the government to conduct a comprehensive review of opportunities for Norwegian production capacity in pharmaceuticals, including which medicines existing production facilities could shift to producing within various timeframes during an emergency situation.